Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.38 |
| ▸ | CCKBR | P32239 | 2/20 | 0.36 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23995637 | 0.89 | GLP1R (0.34) | GLP1RCCKBRCAPN1 | |
| SCHEMBL20380968 | 0.77 | ALDH1A1 (0.44) | CAPN1ALDH1A1 | |
| SCHEMBL22566705 | 0.76 | GLP1R (0.46) | GLP1RCCKBRCAPN1 | |
| SCHEMBL25847264 | 0.76 | ALDH1A1 (0.41) | ALDH1A1 | |
| SCHEMBL18715475 | 0.76 | GLP1R (0.48) | GLP1RCCKBRCAPN1 | |
| SCHEMBL19450704 | 0.75 | CAPN1 (0.37) | GLP1RCCKBRCAPN1 | |
| SCHEMBL22373639 | 0.73 | CAPN1 (0.38) | CAPN1 | |
| SCHEMBL22388954 | 0.72 | KMT2A (0.36) | CAPN1ALDH1A1 | |
| SCHEMBL20362595 | 0.72 | CASP2 (0.47) | ALDH1A1 | |
| SCHEMBL19543472 | 0.72 | CCKBR (0.52) | GLP1RCCKBRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200297865-A1 | CONJUGATES COMPRISING SELF-IMMOLATIVE GROUPS AND METHODS RELATED THERETO | LIGACHEM BIOSCIENCES INC. (KR) | 2020-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200297865-A1 | CONJUGATES COMPRISING SELF-IMMOLATIVE GROUPS AND METHODS RELATED THERETO | LPO, NOXO1, DAO | GLP1R 1774/4885CCKBR 3144/4885CAPN1 2978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.